Indoco Remedies facilities receive USFDA nod
US drug regulator has granted approvals for the company's sterile and solid dosage manufacturing facilities
Indoco Remedies has received a nod from the US Food and Drug Administration (USFDA) for two of its facilities in Goa. The company has received Establishment Inspection Report (EIR) approving the company’s sterile manufacturing facility (plant II) and solid dosage manufacturing facility (plant III) located in Verna, Goa, Indoco Remedies said in a statement.
The company derived 35% of its revenues from exports in 2013-14.
The company derived 35% of its revenues from exports in 2013-14.